(Q41165871)

27 September 2017

title

Central and Renal Circulation, Renin and Aldosterone in Plasma during Prazosin Treatment in Essential Hypertension (English)

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB13552.X

28 June 2022

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB13552.X

28 June 2022

author name string

D. K. Falch

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A394581

28 June 2022

A. Q. Paulsen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A394581

28 June 2022

A. E. Odegaard

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A394581

28 June 2022

N. Norman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A394581

28 June 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=394581

28 June 2022

publication date

1 January 1979

1 reference

full work available at URL

27 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.0954-6820.1979.tb13552.x

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB13552.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.0954-6820.1979.tb13552.x/fullpdf

28 June 2022

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB13552.X

28 June 2022

published in

Acta medica Scandinavica

1 reference

27 September 2017

volume

206

1 reference

27 September 2017

issue

6

1 reference

27 September 2017

page(s)

489-494

1 reference

Effects of prazosin on forearm resistance and capacitance vessels

27 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB13552.X

Renal function in the separate kidneys of man. II. Hemodynamics and excretion of solute and water in essential hypertension

28 June 2022

3

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB13552.X

A preliminary clinical trial of Prazosin: a new oral antihypertensive agent

28 June 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB13552.X

EFFECTIVE RENAL BLOOD FLOW IN THE SEPARATE KIDNEYS OF SUBJECTS WITH ESSENTIAL HYPERTENSION.

28 June 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB13552.X

Oral hydralazine therapy for chronic refractory heart failure

28 June 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB13552.X

Use of prazosin in management of hypertension in patients with chronic renal failure and in renal transplant recipients

28 June 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB13552.X

Mechanisms regulating renin release

28 June 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB13552.X

Evidence for hemodynamic autoregulation of renin release

28 June 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB13552.X

The cardiac response to a small i.v. dose of dihydralazine, a safe drug for diagnostic tests?

28 June 2022

12

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB13552.X

Renal plasma flow and cardiac output during hydralazine and propranolol treatment in essential hypertension

28 June 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB13552.X

Pulmonary blood volume and interventricular circulation time in physically trained and untrained subjects

28 June 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB13552.X

Prazosin: the first-dose phenomenon

28 June 2022

15

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB13552.X

Changes in plasma volume and extracellular fluid volume and after addition of hydralazine to propranolol treatment in patients with hypertension

28 June 2022

19

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB13552.X

Physiologic evaluation of a new antihypertensive agent: prazosin HCl

28 June 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB13552.X

Appraisal and reappraisal of cardiac therapy: prazosin

28 June 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB13552.X

Haemodynamic long-term effects of prazosin plus tolamolol in essential hypertension

28 June 2022

23

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB13552.X

A comparsion of the effects of prazosin and hydrallazine on blood pressure, heart rate and plasma renin activity in conscious renal hypertensive dogs

28 June 2022

25

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB13552.X

Effects of prazosin on renal function and fluid-electrolyte metabolism

28 June 2022

26

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB13552.X

Systemic and regional hemodynamics in low, normal and high cardiac output borderline hypertension

28 June 2022

27

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB13552.X

Effective Plasma Flow of the Individual Kidney. Determination on the Basis of the [131I]Hippuran Renogram

28 June 2022

28

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB13552.X

Cardiovascular and renal adjustments to a hypotensive agent (l'hydrazinophthalazine: Ciba BA-5968: apresoline)

28 June 2022

33

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB13552.X

Experience with prazosin in the treatment of patients with severe hypertension

28 June 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB13552.X

Variations in plasma aldosterone and plasma renin activity throughout the menstrual cycle, with special reference to the pre-ovulatory period

19 April 2023

32

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB13552.X

19 April 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=394581

28 June 2022

1 reference